Introduction 7.5032105
: 2.7003784
Ċ 1.1506985
Amid 15.777154
st 0.72412467
Ġthe 0.42294598
Ġongoing 4.015889
Ġchallenges 8.783518
Ġposed 3.4480872
Ġby 0.1723833
Ġthe 0.8250523
Ġglobal 3.534938
Ġpand 8.516921
emic 0.20274082
, 2.880694
ĠEli 13.86011
ĠLilly 0.031766087
Ġ& 2.1734347
ĠCo 0.7524538
, 3.060535
Ġa 1.0638562
Ġrenowned 4.568732
Ġpharmaceutical 0.45191938
Ġcompany 0.48953697
Ġbased 3.056319
Ġin 0.07183663
ĠIndianapolis 0.7971287
, 0.11413284
Ġis 4.521152
Ġanticipated 9.623648
Ġto 0.017976165
Ġreport 3.165927
Ġa 2.1461847
Ġrobust 3.7568789
Ġrise 5.2032537
Ġin 0.022013595
Ġthird 7.498522
- 0.7839676
quarter 0.00788868
Ġprofits 2.6531026
. 1.2929968
ĠAnaly 5.9378953
sts 0.0011450195
Ġremain 5.9179473
Ġoptimistic 1.0557724
Ġabout 1.0331914
Ġthe 0.21640351
Ġcompany 0.52441895
's 0.06343335
Ġfuture 1.6497198
Ġfinancial 4.278625
Ġperformance 1.0858675
Ġdue 3.2412686
Ġto 0.015873317
Ġthe 1.0762259
Ġstrong 3.3731346
Ġdemand 2.3750935
Ġfor 0.13144195
Ġits 0.62026376
Ġinnovative 3.8538172
Ġdrugs 1.4388409
, 1.9223313
Ġcoupled 5.4452553
Ġwith 0.027726602
Ġvarious 7.209147
Ġsuccessful 6.1554794
Ġproduct 1.5034347
Ġlaunches 0.14226852
. 0.90100914
ĠNevertheless 4.8554516
, 0.0029890686
Ġconcerns 4.128266
Ġlo 4.9837217
om 0.0021692342
Ġover 1.219594
Ġthe 0.368384
Ġcompany 0.77197194
's 0.06687716
Ġprofit 8.41482
Ġmargins 0.30712795
Ġand 2.3928823
Ġits 2.4831126
Ġability 1.7996638
Ġto 0.008027045
Ġsustain 1.425414
Ġthe 1.8080934
Ġcurrent 2.4862144
Ġgrowth 0.9846775
Ġtrajectory 1.3702867
. 0.79247874
ĠAs 5.573721
ĠEli 3.0169208
ĠLilly 0.018701624
Ġ& 1.0737734
ĠCo 0.019322839
Ġprepares 3.6722035
Ġto 0.28345695
Ġrelease 1.7242527
Ġits 0.083349615
Ġearnings 2.8807638
Ġreport 1.421585
, 0.98571795
Ġshareholders 7.173123
Ġand 1.5457437
Ġinvestors 0.97626656
Ġclosely 4.41696
Ġmonitor 0.936164
Ġthe 0.34889147
Ġcompany 0.6574638
's 0.043456443
Ġefforts 5.648528
Ġin 2.1786034
Ġdriving 5.704687
Ġlong 2.475941
- 0.030046353
term 0.010586811
Ġsustainable 3.890559
Ġgrowth 0.17561722
Ġwhile 3.9324532
Ġaddressing 3.5826154
Ġmargin 7.90911
Ġpressures 1.0973126
. 0.6768536
Ċ 0.65842134
Strong 8.280341
ĠSales 3.7293487
ĠPerformance 3.9264972
ĠAmid 4.222121
st 0.23453234
ĠPand 9.215783
emic 0.04871374
: 1.2481449
Ċ 0.15327504
E 1.6744232
li 0.0023872291
ĠLilly 0.010436165
Ġ& 0.14914599
ĠCo 0.017567711
's 1.8091029
Ġoptimistic 8.623563
Ġfinancial 2.898741
Ġoutlook 1.1297259
Ġis 0.57871366
Ġprimarily 1.6238552
Ġattributed 1.2261448
Ġto 0.004429035
Ġits 1.2840545
Ġsolid 3.7688377
Ġsales 1.543274
Ġperformance 0.3277133
Ġin 1.3209085
Ġrecent 3.5228848
Ġmonths 2.7359264
. 0.33885893
ĠThe 0.91462386
Ġcompany 0.13685578
's 0.9429769
Ġportfolio 6.2437525
Ġincludes 3.9520543
Ġcritical 6.37529
Ġmedications 3.2991133
Ġto 2.9182875
Ġtreat 0.5721543
Ġa 2.2035868
Ġrange 1.28233
Ġof 0.0011397669
Ġconditions 2.3411193
, 0.8027822
Ġincluding 0.5366512
Ġdiabetes 1.0474129
, 0.12539297
Ġcancer 1.3701973
, 0.27543098
Ġand 1.7724286
ĠAlzheimer 2.5894842
's 0.013763026
Ġdisease 0.27615923
, 2.8213525
Ġamong 0.83570445
Ġothers 0.09370885
. 0.038497437
ĠDuring 3.719414
Ġthe 0.086087056
Ġthird 0.9050914
Ġquarter 0.1432352
, 0.40615836
Ġhealthcare 8.161144
Ġproviders 0.44410306
Ġcontinued 1.7343203
Ġto 0.079604104
Ġprescribe 1.9728094
Ġthese 1.9263752
Ġvital 5.9283977
Ġdrugs 0.83334374
, 1.4492208
Ġresulting 2.9279373
Ġin 0.006008322
Ġsubstantial 5.4186726
Ġrevenue 1.8473696
Ġgrowth 0.7467409
Ġfor 1.4991716
Ġthe 0.43984678
Ġcompany 0.07801624
. 0.07439988
Ċ 1.9943123
The 2.8200145
Ġintroduction 6.28079
Ġof 0.03467276
Ġgroundbreaking 6.5337214
Ġtherapies 3.1368527
Ġfurther 5.591309
Ġreinforced 5.15588
ĠEli 1.740488
ĠLilly 0.005568705
Ġ& 0.26717332
ĠCo 0.0066151605
's 0.010212256
Ġmarket 2.992286
Ġposition 0.89948773
. 0.7536773
ĠEarlier 4.845567
Ġthis 0.44065872
Ġyear 0.18382488
, 0.007730283
Ġthe 0.09777919
Ġcompany 0.21670674
Ġlaunched 1.0917944
Ġits 3.5931048
ĠCO 10.130961
VID 4.979951
- 12.93905
19 9.672316
Ġantibody 4.9484043
Ġtreatment 3.61174
, 1.752127
Ġb 8.867471
am 10.780366
lan 16.22139
iv 11.429824
im 7.8454356
ab 1.0908018
, 0.307136
Ġproviding 8.412242
Ġa 1.2409588
Ġpotential 2.5024729
Ġsolution 3.0475357
Ġto 0.49939796
Ġcombat 2.8037486
Ġthe 0.8227489
Ġvirus 4.3861275
. 1.3475742
ĠThe 1.3473417
Ġdrug 1.5395424
Ġhas 2.0283613
Ġwitnessed 6.491995
Ġsignificant 3.7613845
Ġuptake 1.7959942
, 2.074452
Ġwith 1.9370599
Ġdemand 5.0310154
Ġlikely 4.675082
Ġto 0.030331206
Ġremain 1.651802
Ġhigh 2.0107348
Ġin 1.3765559
Ġthe 0.07710772
Ġcoming 1.2079593
Ġquarters 1.0260309
. 0.1141599
ĠThis 4.477442
, 3.074233
Ġcoupled 0.9792996
Ġwith 0.0023087843
Ġstrong 3.047236
Ġearnings 6.4921117
Ġfrom 0.4945646
Ġother 1.6466638
Ġkey 2.2314217
Ġproducts 1.102558
, 0.4296506
Ġhas 2.2634614
Ġdriven 3.1206913
Ġoverall 3.8207152
Ġsales 1.1314652
Ġgrowth 0.88539463
Ġfor 0.8553566
Ġthe 0.21894704
Ġcompany 0.09423397
, 3.0532339
Ġinst 7.961589
illing 0.012080839
Ġconfidence 0.9066536
Ġin 1.086793
Ġinvestors 0.9820837
Ġand 2.3996449
Ġanalysts 0.74559665
Ġalike 2.1887543
. 0.029204914
Ċ 0.26695645
Pro 5.5818777
fit 0.3667068
ĠMarg 0.5000695
ins 0.43977913
ĠUnder 1.9951693
ĠSc 5.1156197
r 0.000306903
ut 4.1080762e-05
iny 0.0009602284
: 0.31731513
Ċ 0.018093111
While 2.2226963
ĠEli 1.1492466
ĠLilly 0.0034697265
Ġ& 0.05615263
ĠCo 0.0040229624
's 0.6518668
Ġprojected 7.3982854
Ġrise 4.2106576
Ġin 0.0038381773
Ġprofits 1.5568167
Ġis 0.99806565
Ġencouraging 2.038308
, 0.12529737
Ġconcerns 2.436577
Ġregarding 3.2561252
Ġits 1.905869
Ġprofit 0.84939724
Ġmargins 0.055017617
Ġpersist 1.8273313
. 0.11575533
ĠThe 0.95772254
Ġpharmaceutical 3.8822227
Ġindustry 1.2451038
Ġis 0.8001784
Ġknown 2.2651918
Ġfor 0.4634248
Ġits 0.65669364
Ġhighly 4.024266
Ġcompetitive 0.5318811
Ġlandscape 1.6233102
Ġand 2.1232555
Ġincreasing 5.7468934
Ġpricing 2.3803654
Ġpressures 0.6549144
. 0.80603886
ĠEli 3.039913
ĠLilly 0.0054918677
Ġ& 0.061879613
ĠCo 0.001672846
, 2.1849084
Ġlike 2.007688
Ġmany 2.1391802
Ġof 0.8329614
Ġits 0.0049109203
Ġpeers 0.24425986
, 0.08518557
Ġfaces 2.3804183
Ġchallenges 2.7423785
Ġassociated 3.8748538
Ġwith 0.0025808313
Ġgeneric 5.491598
Ġcompetitors 4.872566
Ġentering 3.1153429
Ġthe 0.09304837
Ġmarket 0.09201518
Ġwith 2.1565437
Ġlower 2.0801032
- 0.25214255
priced 0.82778376
Ġalternatives 1.312505
. 0.644405
Ċ 1.6620754
The 3.169913
Ġpressure 6.985753
Ġon 0.87593496
Ġprofit 1.5312487
Ġmargins 0.006555463
Ġis 0.9056215
Ġfurther 2.091222
Ġexacerbated 1.2176425
Ġby 0.09761916
Ġrising 2.5637176
Ġresearch 1.7719395
Ġand 0.09408479
Ġdevelopment 0.0068896413
Ġ( 1.051504
R 0.0007869244
& 0.002965932
D 0.00027673383
) 0.0012552998
Ġexpenses 1.0040838
. 0.6733585
ĠDevelop 6.5073357
ing 0.006067329
Ġand 2.451718
Ġbringing 2.1852486
Ġnew 1.3133113
Ġdrugs 0.593103
Ġto 0.06748709
Ġmarket 1.0508627
Ġrequires 1.8477852
Ġsignificant 1.3108004
Ġinvestment 1.4695174
, 0.8953126
Ġresulting 2.4169924
Ġin 0.0016785786
Ġhigher 1.434828
ĠR 0.4886598
& 4.9427246e-05
D 0.00012775393
Ġcosts 0.9790383
. 0.55372643
ĠM 7.7942104
aint 0.04775362
aining 5.586358e-05
Ġa 0.863047
Ġhealthy 2.8791554
Ġbalance 1.1587411
Ġbetween 0.48746827
Ġinvestment 4.127365
Ġin 0.97581255
Ġinnovative 3.4721913
Ġtherapies 2.6132615
Ġand 0.095440656
Ġgenerating 4.4857206
Ġan 5.9855447
Ġacceptable 1.0635585
Ġrate 5.0536833
Ġof 0.0060514375
Ġreturn 0.048363026
Ġhas 3.0248907
Ġbecome 1.1033428
Ġan 2.6532104
Ġindustry 4.2132072
- 0.28529128
wide 0.010513806
Ġchallenge 0.32952335
. 0.35062644
ĠEli 2.6318963
ĠLilly 0.0036579126
Ġ& 0.040585443
ĠCo 0.0044452003
's 1.620123
Ġability 2.7006166
Ġto 0.0059357695
Ġnavigate 3.1166842
Ġthis 0.8364552
Ġdelicate 3.1084013
Ġbalance 0.7455901
Ġwill 0.6617871
Ġbe 1.4088081
Ġcrucial 1.893179
Ġin 0.8145226
Ġsustaining 2.1130104
Ġprofitability 3.6731336
Ġin 0.9527195
Ġthe 0.031758457
Ġlong 0.56784534
Ġrun 0.66292423
. 0.028375896
Ċ 0.10407202
Str 6.9018817
ateg 2.7305899
ies 0.13907532
Ġand 4.2089963
ĠOutlook 3.6319885
: 0.19102482
Ċ 0.028031582
To 2.0422895
Ġaddress 1.7819265
Ġconcerns 4.136109
Ġover 1.1902912
Ġprofit 1.5794612
Ġmargins 0.044089623
, 0.33778742
ĠEli 0.16320686
ĠLilly 0.0029457847
Ġ& 0.014237941
ĠCo 0.0020610031
Ġhas 0.8890527
Ġtaken 2.8422227
Ġproactive 3.5706964
Ġmeasures 0.9738631
. 1.6812984
ĠThe 0.62673897
Ġcompany 0.04832112
Ġhas 0.9733108
Ġpriorit 4.748516
ized 0.010067923
Ġcost 2.8413725
- 0.9285877
management 3.6921248
Ġinitiatives 1.4704679
, 0.9361083
Ġseeking 4.455082
Ġoperational 5.9438148
Ġeffic 0.18306622
iencies 0.00050719705
Ġwhile 3.2895482
Ġcontinuing 4.157335
Ġto 0.08706569
Ġinvest 0.64303124
Ġin 0.051976785
Ġpromising 3.356432
Ġtherapeutic 3.584738
Ġadvancements 6.5402904
. 0.04750776
ĠAdditionally 3.3897977
, 0.0005069586
Ġcollaborations 9.605662
Ġand 2.110457
Ġpartnerships 1.2262383
Ġwith 0.7091088
Ġother 0.7564926
Ġindustry 2.5500233
Ġplayers 0.4435135
Ġhave 1.3509443
Ġenabled 2.3796763
Ġthe 0.9683115
Ġsharing 9.664641
Ġof 0.005894036
ĠR 1.6376671
& 8.4116975e-05
D 0.000689698
Ġcosts 0.5443303
Ġand 1.8952243
Ġrisks 2.1249597
, 0.81254435
Ġhelping 3.2187083
Ġto 0.89956117
Ġmitigate 2.2497013
Ġfinancial 3.1743298
Ġpressures 2.4937384
. 0.3357191
Ċ 0.49114957
E 1.6587647
li 0.0037493268
ĠLilly 0.0033190676
Ġ& 0.023132972
ĠCo 0.001771365
's 1.2244421
Ġfuture 3.5422642
Ġperformance 3.4295561
Ġwill 0.44411385
Ġalso 1.6384147
Ġhinge 1.8507478
Ġon 0.15660694
Ġits 0.5949454
Ġability 0.30753532
Ġto 0.004128237
Ġmaintain 3.0735555
Ġa 1.0068277
Ġrobust 2.663609
Ġproduct 2.4201882
Ġpipeline 0.16952044
. 0.3452432
ĠContinued 6.2130795
Ġsuccess 2.986679
Ġin 1.2471999
Ġnew 3.9055371
Ġdrug 2.0090535
Ġlaunches 0.4988123
Ġwill 0.8038686
Ġbe 1.5870856
Ġvital 2.6049073
Ġfor 1.9887415
Ġrevenue 5.2324204
Ġgrowth 0.20150864
Ġand 1.6838943
Ġcountering 8.29926
Ġpricing 2.5146399
Ġpressures 0.18409325
. 0.21174675
ĠTo 3.2853734
Ġthis 1.0746312
Ġend 0.0532065
, 0.00054089085
Ġthe 0.12352281
Ġcompany 0.020258063
Ġhas 1.0130903
Ġactively 5.727907
Ġpursued 1.4756818
Ġstrategic 2.4541812
Ġacquisitions 1.5278318
Ġand 1.0557035
Ġpartnerships 0.8400888
Ġto 1.0005552
Ġexpand 2.3958883
Ġits 0.06407912
Ġtherapeutic 3.9461315
Ġofferings 1.0882907
. 0.5199271
Ċ 1.1781723
Conclusion 5.5491
: 0.020526579
Ċ 0.032578822
E 0.9030858
li 0.0013687563
ĠLilly 0.0062594833
Ġ& 0.01463487
ĠCo 0.002688703
Ġis 1.5519722
Ġpoised 2.473773
Ġto 0.13452026
Ġreport 0.75425047
Ġstrong 2.1232867
Ġthird 1.1461513
- 0.07179955
quarter 0.0009644044
Ġprofits 1.9546084
, 0.7570733
Ġdriven 0.97089463
Ġby 0.12512593
Ġthe 2.8686092
Ġsustained 3.5499163
Ġdemand 0.99794906
Ġfor 0.026138999
Ġits 0.1728647
Ġinnovative 1.4019654
Ġdrugs 0.9291341
Ġand 1.4329455
Ġsuccessful 2.1959188
Ġproduct 0.15500115
Ġlaunches 0.018397715
. 0.035204265
ĠHowever 1.5677761
, 0.0006061975
Ġchallenges 3.9211094
Ġsurrounding 4.3249254
Ġprofit 0.55984867
Ġmargins 0.013977151
Ġlo 4.7768097
om 2.8087945e-05
Ġlarge 0.7916257
, 0.7915566
Ġas 2.2461197
Ġcompetition 3.7266681
Ġand 2.0138927
ĠR 2.3036394
& 0.00013085242
D 0.0003266982
Ġinvestments 3.674222
Ġplace 3.7662108
Ġdownward 3.4131763
Ġpressure 0.04005175
Ġon 0.041972883
Ġprofitability 2.3859265
. 0.046969816
ĠAs 2.7253883
Ġthe 0.4691663
Ġcompany 0.14745359
Ġworks 4.9498253
Ġtowards 1.6660378
Ġbalancing 4.189944
Ġits 2.0667882
Ġfinancial 3.0841525
Ġgoals 3.0234747
Ġwith 1.7440542
Ġits 2.3102355
Ġcommitment 3.9659674
Ġto 0.097504884
Ġadvancing 4.9017034
Ġmedical 2.8701138
Ġtreatments 3.3361456
, 0.0632805
Ġstakeholders 5.0407248
Ġeagerly 2.7413363
Ġawait 0.26734936
Ġits 1.7572806
Ġstrategic 7.995999
Ġplans 2.4162638
Ġfor 1.3885963
Ġmanaging 7.8250275
Ġthese 1.8941239
Ġconcerns 3.0899463
. 0.18684784
ĠEli 4.8532586
ĠLilly 0.007016404
Ġ& 0.040355667
ĠCo 0.0049110404
's 1.6111878
Ġability 2.5709546
Ġto 0.0059008114
Ġnavigate 1.5691725
Ġthese 0.8445519
Ġchallenges 0.62419415
Ġand 2.256262
Ġsustain 1.4969735
Ġlong 1.5513293
- 0.0047683143
term 0.0013332444
Ġprofitability 1.4909031
Ġwill 0.1623359
Ġinfluence 5.6205907
Ġinvestor 3.211617
Ġsentiment 0.36322498
Ġand 1.6156003
Ġthe 2.0479674
Ġcompany 0.36350155
's 0.0014801384
Ġposition 6.0518594
Ġin 0.3627465
Ġthe 0.059993044
Ġpharmaceutical 1.6107489
Ġindustry 0.44262436
. 0.122068025
